돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 549973생성일: 2026년 10월 27일

Candesartan Cilexetil → 2-Ethoxy-1-((2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-benzimidazole-7-carboxylic acid

https://huagongshe.com/reaction/549973

반응식

참여 물질

역할이름HCID투입량
반응물Candesartan CilexetilHCID 2540—
반응물Trityl chlorideHCID 6456—
반응물HCID 178467389HCID 178467389—
생성물2-Ethoxy-1-((2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-benzimidazole-7-carboxylic acidHCID 10312563—

반응 단계

U.S. Pat. No. 5,196,444 discloses Candesartan cilexetil and a process for its preparation by the reaction of 2-ethoxy-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid with trityl chloride in presence of triethyl amine in methylene chloride and purification by column chromatography gives 2-ethoxy-1-[[2′-(N-triphenylmethyltetrazol-5-yl)-biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid, which upon condensation with cyclohexyl 1-iodoethyl carbonate in presence of potassium carbonate in DMF followed by purification with column chromatography gives a colorless powder which is recrystallized in ethanol yields ‘C’ type crystals of Candesartan cilexitil.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07943780B2
출처 데이터셋uspto-grants-2011_05
ORD IDord-61533736cb9344ae8332c8128e9f2977
출처 메모uspto-grants-2011_05